Therapeutic potential of CB2 targeting in multiple sclerosis

Author： Docagne Fabian   Mestre Leyre   Loría Frida   Hernangómez Miriam   Correa Fernando   Guaza Carmen  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.2, 2008-02, pp. : 185-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of cannabis in multiple sclerosis

By Baker David   Pryce Gareth  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 561-567

Informa Healthcare

Access to resources Recommend Favorite

Review of laquinimod and its therapeutic potential in multiple sclerosis

By Thöne Jan   Gold Ralf  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2545-2552

Informa Healthcare

Access to resources Recommend Favorite

Estrogens as Potential Therapeutic Agents in Multiple Sclerosis

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 87-94

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Vitamin D for Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 15, Iss. 5, 2008-02 ,pp. : 499-505

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of the Cannabinoid CB2 Receptor in Pain Transmission and Therapeutic Potential of Small Molecule CB2 Receptor Agonists

By  

Current Medicinal Chemistry, Vol. 14, Iss. 8, 2007-04 ,pp. : 917-936

Bentham Science Publishers

Access to resources Recommend Favorite